Frontline Workers Reveal How Rural Cameroon Is Cut Off From Neurological Care

In the rural and conflict-scarred regions of Cameroon, a stroke can become a death sentence not because medicine lacks the knowledge to treat it, but because the nearest brain specialist may be hundreds of kilometers away, the nearest MRI machine may not exist at all, and the drugs that slow Parkinson’s disease or dementia are simply absent from pharmacy shelves. A new cross-sectional survey published in BMC Health Services Research has put hard numbers on this crisis, drawing on the firsthand experience of 159 healthcare workers who deliver care in some of the country’s most difficult environments. The study, led by Mundih Noelar Njohjam of the Neurological Diseases Association in Bamenda and Cheikh Anta Diop University in Dakar, offers one of the most detailed pictures to date of how neurological disorders go undiagnosed and untreated at the edge of a strained health system, and it lays out pragmatic, low-cost strategies that could begin to close the gap.

Neurological disorders are among the leading causes of disability worldwide, and in sub-Saharan Africa they fall disproportionately on rural populations, where the burden of conditions such as epilepsy, stroke, and neurodegenerative disease collides with the thinnest coverage of specialist care. Cameroon illustrates the pattern starkly. Although the country has trained neurologists, they are concentrated in urban academic centers, leaving vast rural territories and regions affected by armed conflict effectively unserved. Previous research has described the epidemiology of neurological disease in African settings, but data on the specific barriers that frontline workers face, and on which solutions might realistically work, have remained scarce. The new study was designed to fill that void by asking the people who actually staff rural clinics and conflict-zone health posts what they see every day.

The research team conducted an online cross-sectional survey between August and December 2024, recruiting healthcare workers with direct experience in rural and conflict-affected delivery settings across Cameroon. The respondent pool reflected the reality of who provides care outside cities: nurses made up 41.7 percent of participants and non-specialist physicians 30.6 percent, meaning that the vast majority of neurological care in these areas is delivered by clinicians without formal neurology training. The investigators collected information across four domains, workforce, infrastructure, medications, and referral systems, and analyzed the quantitative data descriptively, while open-ended responses were examined thematically to surface recurring obstacles and proposed remedies.

The infrastructure findings are perhaps the most striking. Not a single respondent reported access to magnetic resonance imaging, the workhorse of modern neurological diagnosis, in their setting. Electroencephalography, a far cheaper technology that is indispensable for evaluating epilepsy, was available to only 5.5 percent of respondents. In practical terms, this means that a patient presenting with seizures, progressive weakness, or cognitive decline in these communities cannot receive the basic objective testing that would distinguish epilepsy from a structural lesion, or that would guide treatment for a tumor, hydrocephalus, or demyelinating disease. Diagnosis therefore rests almost entirely on clinical acumen, and when that acumen is unsupported by imaging or electrophysiology, misdiagnosis and delayed treatment become the default rather than the exception.

The medication picture is equally bleak. Essential drugs for neurodegenerative conditions, including dopaminergic agents used in Parkinson’s disease and the cognitive therapies used in dementia, were reported as unavailable in these settings. For a chronic, progressive disorder, an interrupted supply chain is not a minor inconvenience; it can erase years of therapeutic benefit and accelerate functional decline. The survey also documented severe constraints on specialist input: 63.9 percent of respondents said they had difficulty accessing a neurologist for consultation, and 13.9 percent reported having no access whatsoever. In other words, for roughly one in seven of these frontline clinicians, there is no pathway at all, however slow, to reach a brain specialist when a case exceeds their expertise.

Layered on top of these structural deficits is a crisis of confidence. More than 80 percent of respondents rated their confidence in managing neurological conditions as low to moderate, a figure that the authors interpret as a direct consequence of inadequate training exposure and the absence of specialist mentorship. This matters because self-efficacy shapes clinical behavior: a nurse who feels unequipped to distinguish a transient ischemic attack from a migraine may default to referral, and when referral itself is blocked by distance and cost, the patient falls through every layer of the system simultaneously. The thematic analysis of qualitative responses reinforced the quantitative findings, identifying long travel distances, crushing financial constraints on patients, and sociocultural factors, above all stigma attached to neurological illness, as recurring barriers that keep people from seeking care even when services nominally exist.

Conflict adds a further, brutal dimension. In regions of Cameroon affected by insecurity, respondents described how violence, road blockades, and lockdowns physically severed patients from facilities and severed health workers from their posts. Curfews and ghost-town days, imposed during periods of escalation, can suspend routine care for days at a time, and patients with epilepsy who depend on continuous antiseizure medication face the risk of status epilepticus when supply lines break. The study’s framing of these as actionable barriers is deliberate: while the underlying conflict may be beyond the reach of health planners, the survey argues that contingency measures, decentralized drug stocks, and task-shifting protocols can be designed specifically to withstand such shocks.

The pragmatic strategies highlighted by the authors follow from the diagnosis of the problem. Because nurses and non-specialist physicians deliver most of the care, the highest-yield intervention is targeted training: short, structured courses in neurological triage and management, supported by simple clinical algorithms and decision aids, can raise diagnostic accuracy without requiring a single new scanner. Telemedicine emerges as another central recommendation, since mobile connectivity can link a rural health post to a neurologist in Yaoundé or even in the diaspora, converting the 63.9 percent who struggle to reach specialist advice into a connected network. Strengthening referral systems, subsidizing transport for emergency cases, and integrating essential neurological medications into existing essential medicines lists and supply chains are all low-cost measures that the survey identifies as feasible within current resource constraints. Community engagement to dismantle stigma, working through traditional and religious leaders, addresses the sociocultural half of the access problem that no drug or device can solve alone.

The study’s limitations are those inherent to its design: an online survey necessarily samples health workers with internet access, and self-reported confidence and access may not perfectly match objective facility audits. The authors also note that the respondent pool, while broad, cannot capture the experiences of community members who never reach a health facility at all, meaning the true scale of unmet need is likely larger than the survey suggests. Nevertheless, by grounding every recommendation in the reported experience of the clinicians who actually hold the system together, the research avoids the trap of prescribing urban solutions to rural problems.

The broader significance of the work extends well beyond Cameroon. Across much of sub-Saharan Africa, the ratio of neurologists to population remains orders of magnitude below what high-income countries consider standard, and conflict-affected regions from the Sahel to the Horn of Africa face the same compound barriers of distance, insecurity, cost, and stigma documented here. The Cameroon study contributes a replicable methodology, asking frontline workers directly, and a replicable conclusion: neurological care in resource-limited settings will not be fixed by waiting for specialists and MRI machines to arrive, but by equipping the existing workforce with training, connectivity, reliable drug supplies, and referral pathways that survive the shocks of poverty and war. As the authors conclude, strengthening care will require a multipronged approach, and the survey provides the evidence base for choosing which prongs to pull first.

Subject of Research: Barriers to neurological care in rural and conflict-affected communities in Cameroon

Article Title: Neurological care in rural and conflict-affected communities in Cameroon: insights from frontline health workers and pragmatic strategies for improvement

Article References: Njohjam, M. N., Mbouleup, T. F., Ngoule, M. O., & Mondomobe, A. C. (2026). Neurological care in rural and conflict-affected communities in Cameroon: insights from frontline health workers and pragmatic strategies for improvement. BMC Health Services Research. https://doi.org/10.1186/s12913-026-15802-6

Image Credits: AI Generated

DOI: 10.1186/s12913-026-15802-6

Keywords: neurological disorders, Cameroon, rural health, conflict-affected settings, health services research, health workforce, telemedicine, epilepsy, Parkinson's disease, stigma, referral systems, global health